Skip to main content

Raphon Side Effects

Generic name: epinephrine topical

Medically reviewed by Last updated on May 6, 2024.

Note: This document contains side effect information about epinephrine topical. Some dosage forms listed on this page may not apply to the brand name Raphon.

Applies to epinephrine topical: nasal solution.

Serious side effects of Raphon

WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect:

Other side effects of Raphon

All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if you have any side effects that bother you or do not go away.

These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at 1-800-332-1088. You may also report side effects at

For Healthcare Professionals

Applies to epinephrine topical: topical solution.


Cardiovascular side effects have included elevations in heart rate or blood pressure in up to 55% and arrhythmias in 3% to 17% (including fatal ventricular arrhythmias) when used to treat cardiac arrest. In smaller doses, epinephrine has caused peripheral coronary arterial vasodilation, but in larger doses, epinephrine has caused diffuse vasoconstriction. This has caused increased peripheral vascular resistance, which was important in patients with coronary artery disease (worsened myocardial ischemia/angina) or hypertension (risk of emergent hypertension/stroke). Dilated cardiomyopathy and acute left ventricular dysfunction have been associated with the use of epinephrine.[Ref]

Epinephrine can induce hypokalemia with resultant T wave changes on the electrocardiogram.

Rare cases of myocardial infarction have been associated with relatively small doses of epinephrine in patients at risk for coronary artery disease.

Rare cases of cardiomyopathy have been associated with brief and chronic exposure to epinephrine (including inhaled epinephrine). Animal studies have shown that catecholamines can cause an influx of calcium into myocardial cells, which may cause myocardial injury, particularly during periods of epinephrine-induced coronary vasoconstriction. Limited animal data suggest that calcium antagonists may protect against the cardiotoxic effects of catecholamines by preventing the generation of plasma borne cytotoxic compounds, which are probably free radicals.

Epinephrine may be more arrhythmogenic in some patients, such as patients with congenital long QT syndrome.[Ref]

Nervous system

Nervous system side effects have included fear, agitation, anxiety, tenseness, restlessness, headache, tremor, dizziness, lightheadedness, nervousness, sleeplessness, excitability, weakness, and increased parkinsonian tremors. Complications associated with epidural anesthesia with epinephrine have included nerve root ischemia and clinical paralysis/plegia..[Ref]


Respiratory side effects have rarely included pulmonary edema. In some cases, acute left ventricular dysfunction has been documented in the presence of epinephrine-induced pulmonary edema. In some patients, epinephrine has precipitated severe, prolonged asthmatic attacks.[Ref]


Hypersensitivity side effects have been extremely unusual. Contact dermatitis has been associated with ocularly applied epinephrine. These reactions have typically presented with lid edema and a thick yellow discharge.[Ref]


Local side effects have included local tissue ischemia after repeated injections. Chronic IM epinephrine injections have induced local vasoconstriction, predisposing patients to Clostridial infections.[Ref]


Metabolic side effects have included severe metabolic acidosis because of elevated blood concentrations of lactic acid after prolonged use of intravenous epinephrine. Catecholamines have induced glycogenolysis, elevated blood glucose and insulin concentrations, and hypokalemia. Rare cases of hyperglycemia and acidosis have been associated with high catecholamine states, such as anaphylaxis.[Ref]


Psychiatric side effects have included agitation, disorientation, impaired memory, aggressive or assaultive behavior, hallucinations, and psychosis.[Ref]


Renal side effects have included new or worsened renal insufficiency in adult survivors of cardiac arrest, adults who underwent epinephrine-assisted venography, and in rare pediatric cases.[Ref]

Mattana and Singhal reviewed 420 consecutive cases of cardiac arrest and found a 28.6% incidence of acute renal failure (ARF) among patients who survived for at least 24 hours after cardiac arrest. Patients in whom ARF developed received markedly higher doses of epinephrine during resuscitative efforts than patients without ARF. High doses of epinephrine were associated with a longer duration of cardiopulmonary resuscitation. The patients with ARF had a significantly decreased survival rate. It is possible that patients with severe cardiac disease were less resuscitatable, required more epinephrine, and were prone to develop ARF anyway. Other data have failed to associated ARF with the use of high dose epinephrine.[Ref]


1. Whelan TV (1987) "Propranolol, epinephrine, and accelerated hypertension during hemodialysis." Ann Intern Med, 106, p. 327

2. Verrill PJ (1975) "Adverse reactions to local anaesthetics and vasoconstrictor drugs." Practitioner, 214, p. 380-7

3. Haft JI (1974) "Cardiovascular injury induced by sympathetic catecholamines." Prog Cardiovasc Dis, 17, p. 73-86

4. Clutter WE, Bier DM, Shah SD, Cryer PE (1980) "Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man." J Clin Invest, 66, p. 94-101

5. Maguire WM, Reisdorff EJ, Smith D, Wiegenstein JG (1990) "Epinephrine-induced vasospasm reversed by phentolamine digital block." Am J Emerg Med, 8, p. 46-7

6. McManus BM, Fleury TA, Roberts WC (1981) "Fatal catecholamine crisis in pheochromocytoma: curable cause of cardiac arrest." Am Heart J, 102, p. 930-2

7. Ferry DR, Henry RL, Kern MJ (1986) "Epinephrine-induced myocardial infarction in a patient with angiographically normal coronary arteries." Am Heart J, 111, p. 1193-5

8. Fyfe AI, Daly PA, Dorian P, Tough J (1991) "Reversible "cardiomyopathy" after accidental adrenaline overdose." Am J Cardiol, 67, p. 318-9

9. Piscatelli RL, Fox LM (1968) "Myocardial injury from epinephrine overdosage." Am J Cardiol, 21, p. 735-7

10. Lansche RK (1966) "Systemic reactions to topical epinephrine and phenylephrine." Am J Ophthalmol, 61, p. 95-8

11. Webster NR, Hinton W (1986) "Topical adrenaline." Anaesthesia, 41, p. 435

12. Speer F, Tapay NJ (1970) "Syncope in children following epinephrine." Ann Allergy, 28, p. 50-4

13. Brummett RE (1984) "Warning to otolaryngologists using local anesthetics containing epinephrine. Potential serious reaction occurring in patients treated with beta-adrenergic receptor blockers." Arch Otolaryngol, 110, p. 561

14. Taub SJ (1969) "Reactions to aerosol therapy." Eye Ear Nose Throat Mon, 48, p. 653-4

15. Roy RC, Weeks DB (1985) "Otolaryngologists using local anesthetics containing epinephrine." Arch Otolaryngol, 111, p. 280-1

16. Ward CF (1985) "Otolaryngologists using local anesthetics containing epinephrine." Arch Otolaryngol, 111, p. 281

17. (2022) "Product Information. EPINEPHrine Hydrochloride (EPINEPHrine)." Abbott Pharmaceutical

18. Kalsner S (1993) "High-dose epinephrine in cardiopulmonary resuscitation." N Engl J Med, 328, p. 735

19. Tisdale JE, Patel RV, Webb Cr, Borzak S, Zarowitz BJ (1995) "Proarrhythmic effects of intravenous vasopressors." Ann Pharmacother, 29, p. 269-81

20. Tang WC, Weil MH, Sun SJ, Noc M, Yang LY, Gazmuri RJ (1995) "Epinephrine increases the severity of postresuscitation myocardial dysfunction." Circulation, 92, p. 3089-93

21. (2022) "Product Information. Adrenalin (EPINEPHrine)." Apothecon Inc

22. Hartman MM (1969) "Capabilities and limitations of major drug groups in allergy: their role within current theories." Ann Allergy, 27, p. 164-81

23. Gibbs RC (1970) "Allergic contact dermatitis to epinephrine." Arch Dermatol, 101, p. 92-4

24. Romaguera C, Grimalt F (1980) "Contact dermatitis from epinephrine." Contact Dermatitis, 6, p. 364

25. Brown C, Martin D, Pepe P (1993) "High-dose epinephrine in cardiopulmonary resuscitation." N Engl J Med, 328, p. 735-6

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.